Stocks to Watch: Entrada, Blucora, Super Micro Computer – MarketWatch
By Patrick Chu
Entrada Therapeutics Inc. received a clinical hold notice from the Food and Drug Administration regarding its investigational drug application for ENTR-601-44, a potential treatment of Duchenne muscular dystrophy. Entrada shares plunged 29% in after-hours trading.
Blucora Inc. plans to buy back $250 million in shares through a modified Dutch Auction tender offer in the first quarter. The board of the data solutions provider also authorized the repurchase of up to $200 million in shares. The stock advanced 15% in after hours.
Super Micro Computer Inc. will be added to the S&P MidCap 400 index, effective Thursday, S&P Dow Jones Indices said. Shares gained 6% in after hours.
Write to Patrick Chu at Patrick.Chu@WSJ.com
Previous periods of low valuations have resulted in big comebacks for smaller companies.
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More.
Visit a quote page and your recently viewed tickers will be displayed here.